Adams Eric A
- SEC CIK
- 0001817882
No open-market purchases or sales filed in the past year.
Current role at each company
- INM InMed Pharmaceuticals Inc.President & CEOas of Dec 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Adams Eric A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 (view filing)2:58 PM ET | Feb 20 | 1 day | Adams Eric APresident & CEO | PPurchase | +41.6K | $0.3587 | +$14.9K | +1,763.5%44.0K after | |
| Apr 18, 2022 (view filing) | Apr 14 | 4 days | Adams Eric APresident & CEO | PPurchase | +14.2K | $0.89 | +$12.6K | +31.6%59.0K after | |
| Apr 13, 2022 (view filing) | Apr 13 | Same day | Adams Eric APresident & CEO | PPurchase | +8.56K | $0.85 | +$7.28K | +23.6%44.8K after | |
| Sep 30, 2021 (view filing) | Sep 29 | 1 day | Adams Eric APresident & CEO | PPurchase | +8.80K | $1.73 | +$15.2K | +32.0%36.3K after | |
| Sep 29, 2021 (view filing) | Sep 28 | 1 day | Adams Eric APresident & CEO | PPurchase | +11.4K | $1.75 | +$19.9K | +70.9%27.5K after |